The evaluation of free influenza vaccination in health care workers in a medical center in Taiwan

被引:19
作者
Chan, Agnes L. F.
Shie, Huei-Jen
Lee, Yung-Jin
Lin, Shun-Jin
机构
[1] Kaohsiung Med Univ, Inst Pharm, Kaohsiung 807, Taiwan
[2] Chi Mei Med Ctr, Dept Pharm, Tainan, Taiwan
[3] Chi Nan Univ Pharm & Sci, Tainan, Taiwan
[4] Kahsiung Med Univ, Grad Inst Pharm, Kaohsiung, Taiwan
来源
PHARMACY WORLD & SCIENCE | 2008年 / 30卷 / 01期
关键词
adverse drug reactions; cost; healthcare worker; influenza; influenze vaccine; Taiwan;
D O I
10.1007/s11096-007-9137-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective To evaluate the outcome of free influenza vaccination for healthcare workers in Taiwan. Method A retrospective observational study was conducted in a partially vaccinated sample of healthcare workers in a medical centre in the southern part of Taiwan. A convenience sample of 500 employees received a questionnaire. Main outcome measure Incidence of influenza like- illness (ILI), rates of absenteeism and costs savings. Results A final number of 407 returned questionnaires could be evaluated. Forty respondents were not vaccinated. The incidence of ILI was lower in the vaccinated group than the nonvaccinated group (13.6 vs. 15%). Fever was the most frequently occurring ILI. Rate of absenteeism because of ILI in the non-vaccinated employees was higher than in the group of vaccinated employees. The costs per saved lost working day was US $ 36. Conclusion Free influenza vaccination may cause reductions in incidence, absenteeism, and costs associated with ILI in healthcare workers in Taiwan.
引用
收藏
页码:39 / 43
页数:5
相关论文
共 14 条
  • [1] Economic costs of influenza-related work absenteeism
    Akazawa, M
    Sindelar, JL
    Paltiel, AD
    [J]. VALUE IN HEALTH, 2003, 6 (02) : 107 - 115
  • [2] [Anonymous], COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD001269.PUB2.ART
  • [3] Effectiveness and cost-benefit of influenza vaccination of healthy working adults - A randomized controlled trial
    Bridges, CB
    Thompson, WW
    Meltzer, MI
    Reeve, GR
    Talamonti, WJ
    Cox, NJ
    Lilac, HA
    Hall, H
    Klimov, A
    Fukuda, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (13): : 1655 - 1663
  • [4] *CDCP, 2005, MMWR-MORBID MORTAL W, V4, P54
  • [5] Influenza - Cost of illness and considerations in the economic evaluation of new and emerging therapies
    Cram, P
    Blitz, SG
    Monto, A
    Fendrick, AM
    [J]. PHARMACOECONOMICS, 2001, 19 (03) : 223 - 230
  • [6] Prevention and early treatment of influenza in healthy adults
    Demicheli, V
    Jefferson, T
    Rivetti, D
    Deeks, J
    [J]. VACCINE, 2000, 18 (11-12) : 957 - 1030
  • [7] DOUGLAS CS, 1997, J OCCUP ENVIRON MED, V39, P408
  • [8] GUPA RD, 2002, PHARMACOECONOMICS, V20, P475
  • [9] Costs and benefits of influenza vaccination and work productivity in a Colombian company from the employer's perspective
    Morales, A
    Martinez, MM
    Tasset-Tisseau, A
    Rey, E
    Baron-Papillon, F
    Follet, A
    [J]. VALUE IN HEALTH, 2004, 7 (04) : 433 - 441
  • [10] THE EFFECTIVENESS OF VACCINATION AGAINST INFLUENZA IN HEALTHY, WORKING ADULTS
    NICHOL, KL
    LIND, A
    MARGOLIS, KL
    MURDOCH, M
    MCFADDEN, R
    HAUGE, M
    MAGNAN, S
    DRAKE, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (14) : 889 - 893